Balance sheet of Beryl Drugs is strong.
It shouldn't have solvency or liquidity issues.

Yes, The debt of Beryl Drugs is increasing.
Latest debt of Beryl Drugs is ₹4.75 Crs as of Mar-24.
This is greater than Mar-23 when it was ₹3.57 Crs.

The profit is oscillating.
The profit of Beryl Drugs is ₹0.77 Crs for Mar 2024, ₹0.77 Crs for Mar 2023 and -₹0.66 Crs for Mar 2022

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Beryl Drugs latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are allocated to majorly productive assets like Plant & Machinery and unproductive assets like Inventory, Accounts Receivable